Effects of genetic polymorphisms of apolipoprotein A1 on serum HDL cholesterol level in postmenopausal Korean women

다국어 초록 (Multilingual Abstract)

Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) cholesterol in blood, and ApoA1 genetic polymorphisms modulate the blood lipid profiles. This study was conducted in order to investigate the association between three genetic polymorphisms (rs670, rs5069, and rs5070) of ApoA1 and blood lipid profiles in postmenopausal Korean women. A total of 130 postmenopausal women who visited a hospital in order to undergo screening tests were subjects of this study. Genetic polymporphisms and blood lipid profiles were determined using a direct sequencing and spectrophotometric assay, respectively. A significant linkage disequilibrium was observed between all tested single nucleotide polymorphisms. ApoA1 rs5070 genetic polymorphism showed a marginally significant association with HDL cholesterol levels (p=0.066). After adjusting for age, body mass index, smoking, alcohol drinking, medication, hypertension, and diabetes mellitus, we found that the ApoA1 rs5070 genetic polymorphism is a significant determinant of HDL cholesterol levels (β=4.421, p=0.037). According to the results of this study, ApoA1 rs5070 genetic polymorphism may be an important genetic marker associated with HDL cholesterol in postmenopausal Korean women.

참고문헌 (Reference)

1 김도희, "한국 폐경 여성에서 APOA5 유전자 다형성과 대사증후군의 연관성" 대한내분비학회 27 (27): 276-281, 2012

2 문기은, "건강한 여성 근로자에서 Apolipoprotein E와 혈중 지질 농도와의 관련성" 대한예방의학회 43 (43): 213-221, 2010

3 문재연, "건강한 성인 남녀에서 Apolipoprotein A-Ⅰ 유전자 다형성과 혈중 지질농도와의 연관성" 대한심장학회 34 (34): 1158-1166, 2004

4 Davidson WS, "The structure of apolipoprotein A-I in high density lipoproteins" 282 : 22249-22253, 2007

5 Kwiterovich PO, "The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review" 86 : 5-10, 2000

6 Bush TL, "The epidemiology of cardiovascular disease in postmenopausal women" 592 : 263-271, 1990

7 Shin Min Ho, "The Effect of Apolipoprotein E Polymorphism on Lipid Levels in Korean Adults" 대한의학회 20 (20): 361-366, 2005

8 Hulley S, "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group" 280 : 605-613, 1998

9 Smith JD, "Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro" 89 : 1796-1800, 1992

10 Williamson R, "Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I" 89 : 7134-7138, 1992

11 Kim CJ, "Influence of menopause on high density lipoprotein-cholesterol and lipids" 15 : 380-386, 2000

12 World Health Organization, "Global atlas on cardiovascular disease prevention and control" World Health Organization 2011

13 Wang X, "Genetics of variation in HDL cholesterol in humans and mice" 96 : 27-42, 2005

14 Boes E, "Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review" 44 : 136-160, 2009

15 Heller DA, "Genetic and environmental influences on serum lipid levels in twins" 328 : 1150-1156, 1993

16 Middelberg RP, "Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause" 22 : 1142-1147, 2002

17 Harnish DC, "Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing" 273 : 9270-9278, 1998

18 Stefanick ML, "Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol" 339 : 12-20, 1998

19 Florvall G, "Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men" 61 : 1262-1266, 2006

20 Shioji K, "An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese" 49 : 433-439, 2004